LUMOS PHARMA, INC. ((LUMO)) is a publicly traded company in the Unknown sector. Across all available filings, 16 corporate insiders have executed 125 transactions totaling $3.2M, demonstrating a bullish sentiment with $3.0M in net insider flow. The most recent transaction on Aug 6, 2024 involved a sale of 3,407 shares valued at $6.4K.
No significant insider buying has been recorded for (LUMO) in the recent period.
No significant insider selling has been recorded for (LUMO) in the recent period.
Based on recent SEC filings, insider sentiment for (LUMO) is bullish with an Insider Alignment Score of 97/100 and a net flow of $3.0M. Insiders are accumulating shares, which historically signals confidence in the company's future performance.
Insider trading at LUMOS PHARMA, INC. ((LUMO)) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 16 insiders are actively trading (LUMO) stock, having executed 125 transactions in the past 90 days. The most active insider is Kevin M. Lalande (Executive), who has made 21 transactions totaling $2.9M.
Get notified when executives and directors at (LUMO) file new Form 4 transactions
Date | Insider | Title | Type | Shares | Price | Value | Flags |
|---|---|---|---|---|---|---|---|
| Aug 6, 2024 | C. Mckew John | Executive | Sale | 3,407 | $1.89 | $6.4K | 10b5-1 |
| Aug 1, 2024 | C. Mckew John | Executive | Payment | 1,593 | $1.79 | $2.9K | |
| Aug 1, 2024 | D. Lawley Lori | Executive | Payment | 229 | $1.79 | $410 | |
| Jul 1, 2024 | Duke Pitukcheewanont Pisit | Executive | Payment | 274 | $2.26 | $619 | |
| Jun 1, 2024 | Duke Pitukcheewanont Pisit | Executive | Payment | 320 | $2.25 | $720 | |
| Apr 3, 2024 | C. Mckew John | Executive | Sale | 2,214 | $2.78 | $6.2K | 10b5-1 |
| Apr 1, 2024 | Schuchart Aaron | Executive | Award | 1,000 | $2.84 | $2.8K | |
| Apr 1, 2024 | J. Hawkins Richard | Executive | Award | 4,500 | $2.84 | $12.8K | |
| Apr 1, 2024 | J. Hawkins Richard | Executive | Payment | 1,522 | $2.84 | $4.3K | |
| Apr 1, 2024 | C. Mckew John | Executive | Award | 2,000 | $2.84 | $5.7K | 10b5-1 |
| Apr 1, 2024 | C. Mckew John | Executive | Payment | 1,036 | $2.84 | $2.9K | 10b5-1 |
| Apr 1, 2024 | Duke Pitukcheewanont Pisit | Executive | Award | 6,000 | $2.84 | $17.0K | |
| Apr 1, 2024 | D. Lawley Lori | Executive | Award | 1,000 | $2.84 | $2.8K | |
| Apr 1, 2024 | D. Lawley Lori | Executive | Payment | 274 | $2.84 | $778 | |
| Apr 1, 2024 | J. Powers Bradley | Executive | Award | 900 | $2.84 | $2.6K |
| TYPE | COUNT | VALUE | % |
|---|---|---|---|
Purchase(P) | 29 | $3.1M | 88.0% |
Award(A) | 44 | $173.5K | 5.0% |
Payment(F) | 42 | $139.3K | 4.0% |
Sale(S) | 10 | $106.0K | 3.0% |
Insiders at LUMOS PHARMA, INC. are accumulating shares at an accelerated pace. With 16 insiders making 125 transactions totaling $3.1M in purchases versus $106.0K in sales, the net buying activity of $3.0M signals strong executive confidence. Kevin M. Lalande (Executive) leads the buying activity with $2.9M in transactions across all time.